FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072917 [Registered on: 22/08/2024] Trial Registered Prospectively
Last Modified On: 22/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Other 
Public Title of Study   A comparative study to evaluate the insertion of postpartum intrauterine contraceptive device with the new inserter versus Kelly forceps . 
Scientific Title of Study   A prospective, interventional, comparative study to evaluate the insertion of postpartum intrauterine contraceptive device using the dedicated inserter versus Kelly forceps. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Palak 
Designation  Junior resident  
Affiliation  Postgraduate institute of medical education and research ,Chandigarh  
Address  Department of obstetrics and gynaecology ,Nehru hospital ,Postgraduate Institute Of Medical Education And Research , Sector 12,Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  8607465160  
Fax    
Email  palak180299@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vanita Jain 
Designation  Professor  
Affiliation  Postgraduate institute of medical education and research, Chandigarh  
Address  Department of obstetrics and gynaecology , Nehru hospital, Postgraduate Institute Of Medical Education And Research , sector12,Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9914209352  
Fax    
Email  drvanitajain@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vanita jain  
Designation  Professor  
Affiliation  Postgraduate institute of medical education and research, Chandigarh  
Address  Department of obstetrics and gynaecology ,Nehru hospital ,Postgraduate Institute Of Medical Education And Research, sector 12 Chandigarh

Chandigarh
CHANDIGARH
160012
India 
Phone  9914209352  
Fax    
Email  drvanitajain@yahoo.com  
 
Source of Monetary or Material Support  
Department of obstetrics and gynaecology , Postgraduate institute of medical education and research ,sector 12 , Chandigarh 160012. 
 
Primary Sponsor  
Name  Dr Palak 
Address  Department of obstetrics and gynaecology, Nehru hospital, Postgraduate Institute Of Medical Education And Research ,Sector 12 ,160012. 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Palak  Postgraduate institute of medical education and research,Chandigarh 160012  Department of obstetrics and gynaecology, Postgraduate Institute Of Medical Education And Research, Chandigarh 160012
Chandigarh
CHANDIGARH 
8607465160

palak180299@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (Intramural) , Post Graduate Institute Of Medical Education And Research , Chandigarh .   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O909||Complication of the puerperium, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dedicated inserter .   Insertion of contraceptive device with dedicated inserter which is long and does not need a specific instrument . Duration -Follow up after 6 weeks . Frequency - maximum two trials allowed .  
Comparator Agent  Kelly forceps  Insertion of contraceptive device with Kelly forceps which is a conventional instrument . Duration - follow up after 6 weeks Frequency - maximum two trials allowed . 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1 Primiparous or multiparous women delivering vaginally and willing for long term reversible contraception.(Including instrumental deliveries )
2 Consenting and willing for Copper T IUD.
3 Patients who fulfil the WHO Medical eligibility criteria for contraceptive use
4 Insertion within 48 hours following delivery. 
 
ExclusionCriteria 
Details  1 women not willing to participate
2 women with pelvic inflammatory disease
3 cesarean delivery
4 peri partum fever
5 women with anaemia , thrombocytopenia
6 women with postpartum haemorrhage
7 women with chorioamnionitis  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
1 To assess the correct fundal placement of PPIUCD in the uterus.
2 To assess provider’s satisfaction in terms of ease of insertion using five- point LIKERT scale.
 
Immediately after insertion and at 6 weeks postpartum. 
 
Secondary Outcome  
Outcome  TimePoints 
1 To assess patients’ satisfaction and perception of pain using three-point LIKERT scale.
2 Confirmation of PPIUCD retention by a six-week follow-up.
 
6 weeks post partum 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective , interventional , comparative study to evaluate  the insertion of postpartum intrauterine contraceptive device using the dedicated inserter versus Kelly forceps which is the conventional method ;  in terms of fundal placement , ease of insertion for doctor , patient’s perception of pain and any complications .  
Close